Delayed Arterial Healing and Increased Late Stent Thrombosis at Culprit Sites After Drug-Eluting Stent Placement for Acute Myocardial Infarction Patients: An Autopsy Study
暂无分享,去创建一个
Aloke V. Finn | Michael Joner | Renu Virmani | Allen P. Burke | Gaku Nakazawa | Elena Ladich | R. Virmani | A. Finn | F. Kolodgie | M. Joner | G. Nakazawa | H. Gold | A. Burke | E. Ladich | E. Mont | R. Kutys | Frank D. Kolodgie | Robert Kutys | Herman K. Gold | Erik K. Mont
[1] John Bresnahan,et al. Outcomes of Stent Thrombosis and Restenosis During Extended Follow-Up of Patients Treated With Bare-Metal Coronary Stents , 2007, Circulation.
[2] Marco Valgimigli,et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. , 2007, European heart journal.
[3] P. Steg. Drug eluting stents should be used with caution in acute myocardial infarction , 2007 .
[4] Michail I. Papafaklis,et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. , 2007, Journal of the American College of Cardiology.
[5] Michael Joner,et al. Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[6] R. Virmani,et al. Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization , 2007, Circulation.
[7] Rolf Vogel,et al. Incomplete Stent Apposition and Very Late Stent Thrombosis After Drug-Eluting Stent Implantation , 2007, Circulation.
[8] Johan Lindbäck,et al. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. , 2007, The New England journal of medicine.
[9] A. Farb,et al. Stent thrombosis redux--the FDA perspective. , 2007, The New England journal of medicine.
[10] S. Pocock,et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. , 2007, The New England journal of medicine.
[11] Neville Kukreja,et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study , 2007, The Lancet.
[12] E. Bramucci,et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. , 2006, The New England journal of medicine.
[13] J. Tijssen,et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. , 2006, The New England journal of medicine.
[14] Michael Joner,et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.
[15] I. Iakovou,et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. , 2005, JAMA.
[16] E. Edelman,et al. Thrombosis Modulates Arterial Drug Distribution for Drug-Eluting Stents , 2005, Circulation.
[17] E. Edelman,et al. Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[18] S. Doggrell. Sirolimus- versus paclitaxel-eluting stents in patients with stenosis in a native coronary artery , 2004, Expert opinion on pharmacotherapy.
[19] G. Stone,et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. , 2004, The New England journal of medicine.
[20] Renu Virmani,et al. Pathological Mechanisms of Fatal Late Coronary Stent Thrombosis in Humans , 2003, Circulation.
[21] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.
[22] Renu Virmani,et al. Morphological Predictors of Restenosis After Coronary Stenting in Humans , 2002, Circulation.
[23] R. Virmani,et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[24] R. Virmani,et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. , 1997, The New England journal of medicine.
[25] P. Libby,et al. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. , 1995, The American journal of pathology.